SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $41,671,192 |
| Positions | 6 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| ACTUATE THERAPEUTICS INC | ACTU | COM | $15,376,494 | 10,049,996 |
| OPUS GENETICS INC | IRD | COM | $15,138,893 | 3,683,429 |
| COGNITION THERAPEUTICS INC | CGTX | COM | $6,900,001 | 6,000,000 |
| REIN THERAPEUTICS INC | RNTX | COM NEW | $3,101,670 | 2,982,375 |
| LANTERN PHARMA INC | LTRN | COM | $1,039,985 | 249,397 |
| IN8BIO INC | INAB | COM NEW | $114,149 | 80,957 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.